Medicare AdvantageCoverageMedium impact
MA05.047o, Treatment of Obstructive Sleep Apnea (OSA) and Primary Snoring in Adults
Independence Blue Cross·Sleep Medicine, Pulmonology, ENT (Ear, Nose & Throat)·Medical Policy
Effective date
Oct 29, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA05.047o for Treatment of Obstructive Sleep Apnea (OSA) and Primary Snoring in Adults has been reissued with updates effective October 29, 2025. This policy affects sleep medicine billing and coverage determinations for OSA treatments.
Action Required
Before October 29, 2025: Billing team must review the complete updated policy MA05.047o on the IBX Medicare Advantage portal to identify specific changes to OSA treatment coverage, billing requirements, or prior authorization rules. Update billing protocols and staff training accordingly for Medicare Advantage members requiring sleep apnea treatments.